InfuSystem Holdings, Inc Segments Disclosure
| 2025 | ||||||||||||||||||||||||||
| (in thousands) | Patient Services | Device Solutions | Corporate/ Eliminations | Total | ||||||||||||||||||||||
| Net revenues - external | $ | 86,532 | $ | 56,904 | $ | — | $ | 143,436 | ||||||||||||||||||
| Net revenues - internal | — | 7,192 | (7,192) | — | ||||||||||||||||||||||
| Total net revenues | 86,532 | 64,096 | (7,192) | 143,436 | ||||||||||||||||||||||
| Significant Segment Expenses: | ||||||||||||||||||||||||||
| Supplies and material costs | 23,478 | 18,932 | (7,192) | 35,218 | ||||||||||||||||||||||
| Employee-related expenses | — | 16,328 | — | 16,328 | ||||||||||||||||||||||
| Depreciation | 7,357 | 3,787 | — | 11,144 | ||||||||||||||||||||||
| Other segment items (a) | 324 | 126 | — | 450 | ||||||||||||||||||||||
| Gross profit | $ | 55,373 | $ | 24,923 | $ | — | $ | 80,296 | ||||||||||||||||||
| Selling, general and administrative expenses | 68,376 | |||||||||||||||||||||||||
| Interest expense | (1,299) | |||||||||||||||||||||||||
| Other income | 2 | |||||||||||||||||||||||||
| Income before income taxes | $ | 10,623 | ||||||||||||||||||||||||
| Total assets | $ | 53,518 | $ | 45,042 | $ | 2,000 | $ | 100,560 | ||||||||||||||||||
| Purchases of medical equipment | $ | 4,560 | $ | 3,566 | $ | — | $ | 8,126 | ||||||||||||||||||
| Depreciation and amortization of intangible assets | $ | 8,492 | $ | 4,802 | $ | — | $ | 13,294 | ||||||||||||||||||
| (a) Other segment items included in Segment gross profit include estimates for medical equipment that is considered to be missing and other miscellaneous shop expenses. | ||||||||||||||||||||||||||
| 2024 | ||||||||||||||||||||||||||
| (in thousands) | Patient Services | Device Solutions | Corporate/ Eliminations | Total | ||||||||||||||||||||||
| Net revenues - external | $ | 80,378 | $ | 54,483 | $ | — | $ | 134,861 | ||||||||||||||||||
| Net revenues - internal | — | 7,254 | (7,254) | — | ||||||||||||||||||||||
| Total net revenues | 80,378 | 61,737 | (7,254) | 134,861 | ||||||||||||||||||||||
| Significant Segment Expenses: | ||||||||||||||||||||||||||
| Supplies and material costs | 20,255 | 21,948 | (7,254) | 34,949 | ||||||||||||||||||||||
| Employee-related expenses | — | 18,573 | — | 18,573 | ||||||||||||||||||||||
| Depreciation | 6,788 | 3,454 | — | 10,242 | ||||||||||||||||||||||
| Other segment items (a) | 493 | 201 | — | 694 | ||||||||||||||||||||||
| Gross profit | $ | 52,842 | $ | 17,561 | $ | — | $ | 70,403 | ||||||||||||||||||
| Selling, general and administrative expenses | 63,512 | |||||||||||||||||||||||||
| Interest expense | (1,777) | |||||||||||||||||||||||||
| Other expense | (55) | |||||||||||||||||||||||||
| Income before income taxes | $ | 5,059 | ||||||||||||||||||||||||
| Total assets | $ | 54,203 | $ | 47,411 | $ | 2,000 | $ | 103,614 | ||||||||||||||||||
| Purchases of medical equipment | $ | 6,679 | $ | 10,062 | $ | — | $ | 16,741 | ||||||||||||||||||
| Depreciation and amortization of intangible assets | $ | 7,891 | $ | 4,608 | $ | — | $ | 12,499 | ||||||||||||||||||
| (a) Other segment items included in Segment gross profit include estimates for medical equipment that is considered to be missing and other miscellaneous shop expenses. | ||||||||||||||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 27, 2026 | Showing above |
| 2024 | Mar 11, 2025 | |
| 2023 | Apr 10, 2024 | |
| 2022 | Mar 16, 2023 | |
| 2021 | Mar 15, 2022 | |
| 2020 | Mar 22, 2021 | |
| 2019 | Mar 30, 2020 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.